Literature DB >> 33572262

Impact of Diet on Symptoms of the Irritable Bowel Syndrome.

Robin Spiller1.   

Abstract

Irritable bowel syndrome (IBS), with its key features of abdominal pain and disturbed bowel habit, is thought by both patients and clinicians to be strongly influenced by diet. However, the complexities of diet have made identifying specific food intolerances difficult. Eating disorders can masquerade as IBS and may need specialist treatment. While typical food allergy is readily distinguished from IBS, the mechanisms of gut-specific adverse reactions to food are only just being defined. These may include gut-specific mast cell activation as well as non-specific activation by stressors and certain foods. Visceral hypersensitivity, in some cases mediated by mast cell activation, plays a key part in making otherwise innocuous gut stimuli painful. Rapidly fermented poorly absorbed carbohydrates produce gaseous distension as well as short-chain fatty acids and lowering of colonic pH which may cause symptoms in IBS patients. Limiting intake of these in low FODMAP and related diets has proven popular and apparently successful in many patients. Existing diet, colonic microbiota and their metabolic products may be helpful in predicting who will respond. Wheat intolerance may reflect the fact that wheat is often a major source of dietary FODMAPs. It may also be either a forme fruste of coeliac disease or non-specific immune activation. Wheat exclusion can be successful in some of these patients. More research is needed to fully understand the mechanisms of food intolerances and how to best ameliorate them in a personalised medicine approach to diet in IBS.

Entities:  

Keywords:  FODMAP; allergy; diet; fibre; irritable bowel syndrome

Year:  2021        PMID: 33572262      PMCID: PMC7915127          DOI: 10.3390/nu13020575

Source DB:  PubMed          Journal:  Nutrients        ISSN: 2072-6643            Impact factor:   5.717


  128 in total

1.  Psychological features are important predictors of functional gastrointestinal disorders in patients with eating disorders.

Authors:  Catherine Boyd; Suzanne Abraham; John Kellow
Journal:  Scand J Gastroenterol       Date:  2005-08       Impact factor: 2.423

2.  Visceral hypersensitivity is associated with GI symptom severity in functional GI disorders: consistent findings from five different patient cohorts.

Authors:  Magnus Simrén; Hans Törnblom; Olafur S Palsson; Miranda A L van Tilburg; Lukas Van Oudenhove; Jan Tack; William E Whitehead
Journal:  Gut       Date:  2017-01-19       Impact factor: 23.059

3.  Short-chain fatty acid receptor, GPR43, is expressed by enteroendocrine cells and mucosal mast cells in rat intestine.

Authors:  Shin-ichiro Karaki; Retsu Mitsui; Hisayoshi Hayashi; Ikuo Kato; Hiroshi Sugiya; Toshihiko Iwanaga; John B Furness; Atsukazu Kuwahara
Journal:  Cell Tissue Res       Date:  2006-02-01       Impact factor: 5.249

4.  Food-specific serum IgG4 and IgE titers to common food antigens in irritable bowel syndrome.

Authors:  Sameer Zar; Martin J Benson; Devinder Kumar
Journal:  Am J Gastroenterol       Date:  2005-07       Impact factor: 10.864

5.  Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome.

Authors:  Peter J Whorwell; Linda Altringer; Jorge Morel; Yvonne Bond; Duane Charbonneau; Liam O'Mahony; Barry Kiely; Fergus Shanahan; Eamonn M M Quigley
Journal:  Am J Gastroenterol       Date:  2006-07       Impact factor: 10.864

6.  Long-term impact of the low-FODMAP diet on gastrointestinal symptoms, dietary intake, patient acceptability, and healthcare utilization in irritable bowel syndrome.

Authors:  M O'Keeffe; C Jansen; L Martin; M Williams; L Seamark; H M Staudacher; P M Irving; K Whelan; M C Lomer
Journal:  Neurogastroenterol Motil       Date:  2017-07-14       Impact factor: 3.598

7.  Prevalence and presentation of lactose intolerance and effects on dairy product intake in healthy subjects and patients with irritable bowel syndrome.

Authors:  Jianfeng Yang; Yanyong Deng; Hua Chu; Yanqun Cong; Jianmin Zhao; Daniel Pohl; Benjamin Misselwitz; Michael Fried; Ning Dai; Mark Fox
Journal:  Clin Gastroenterol Hepatol       Date:  2012-12-13       Impact factor: 11.382

8.  Effect of coffee on distal colon function.

Authors:  S R Brown; P A Cann; N W Read
Journal:  Gut       Date:  1990-04       Impact factor: 23.059

9.  A controlled trial of gluten-free diet in patients with irritable bowel syndrome-diarrhea: effects on bowel frequency and intestinal function.

Authors:  Maria I Vazquez-Roque; Michael Camilleri; Thomas Smyrk; Joseph A Murray; Eric Marietta; Jessica O'Neill; Paula Carlson; Jesse Lamsam; Denise Janzow; Deborah Eckert; Duane Burton; Alan R Zinsmeister
Journal:  Gastroenterology       Date:  2013-01-25       Impact factor: 22.682

10.  Presentation and Characteristics of Abdominal Pain Vary by Irritable Bowel Syndrome Subtype: Results of a Nationwide Population-Based Study.

Authors:  Eric D Shah; Christopher V Almario; Brennan M Spiegel; William D Chey
Journal:  Am J Gastroenterol       Date:  2020-02       Impact factor: 12.045

View more
  4 in total

Review 1.  Targeting the endocannabinoid system for the treatment of abdominal pain in irritable bowel syndrome.

Authors:  Stuart M Brierley; Beverley Greenwood-Van Meerveld; Giovanni Sarnelli; Keith A Sharkey; Martin Storr; Jan Tack
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-09-27       Impact factor: 73.082

2.  Translational Gap between Guidelines and Clinical Medicine: The Viewpoint of Italian General Practitioners in the Management of IBS.

Authors:  Massimo Bellini; Cesare Tosetti; Francesco Rettura; Riccardo Morganti; Christian Lambiase; Gabrio Bassotti; Pierfrancesco Visaggi; Andrea Pancetti; Edoardo Benedetto; Nicola de Bortoli; Paolo Usai-Satta; Rudi De Bastiani
Journal:  J Clin Med       Date:  2022-07-03       Impact factor: 4.964

Review 3.  Carbohydrate Maldigestion and Intolerance.

Authors:  Fernando Fernández-Bañares
Journal:  Nutrients       Date:  2022-05-04       Impact factor: 6.706

Review 4.  Gut bless you: The microbiota-gut-brain axis in irritable bowel syndrome.

Authors:  Eline Margrete Randulff Hillestad; Aina van der Meeren; Bharat Halandur Nagaraja; Ben René Bjørsvik; Noman Haleem; Alfonso Benitez-Paez; Yolanda Sanz; Trygve Hausken; Gülen Arslan Lied; Arvid Lundervold; Birgitte Berentsen
Journal:  World J Gastroenterol       Date:  2022-01-28       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.